We are live on ! Find out more
NSPR icon

InspireMD

29 hedge funds and large institutions have $29.2M invested in InspireMD in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

12% more funds holding

Funds holding: 2629 (+3)

6.94% more ownership

Funds ownership: 41.33%48.27% (+6.9%)

2% more capital invested

Capital invested by funds: $28.7M → $29.2M (+$558K)

0% more call options, than puts

Call options by funds: $1K | Put options by funds: $1K

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
1
Closed
3
Calls
$1K
Puts
$1K
Net Calls
Net Calls Change
-$303K

NSPR Hedge Fund Activity: Q4 2023 in Review

29 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2023, worth a combined $29.2M — up 1.9% from $28.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NSPR positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $859K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $716K sold.

  • 29 institutional investors held InspireMD (NSPR) as of Q4 2023, up from 26 in Q3 2023.
  • Funds reported $29.2M of InspireMD stock for Q4 2023, up 1.9% quarter-over-quarter.
  • 6 funds opened new InspireMD positions in Q4 2023 and 3 closed out, a net change of +3 holders.
  • The largest InspireMD buyer in Q4 2023 was Nantahala Capital Management, an estimated $859K added.
  • The largest InspireMD seller in Q4 2023 was Point72 Asset Management, an estimated $716K sold.

Based on aggregated 13F filings for Q4 2023.